RIP1 Kinase identified as promising therapeutic target in pancreatic cancer
An experimental drug may be effective against a deadly form of pancreatic cancer when used in combination with other immune-boosting therapies, according to a cover study publishing online Nov. 12 in Cancer Cell.
Nov 12, 2018
0
1